By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



850 bld Sebastien
Brant  Illkirch  67400  France
Phone: 33-0-368-330-200 Fax: 33-0-368-330-201


NovAliX is a private company, owned by its executive management, scientific founders and employees; located in Illkirch near Strasbourg.

Based upon the initial concept of transferring academic knowledge into valuable industrial applications; NovAliX has become a trusted provider of expert services to clients ranging from virtual companies to the global players. NovAliX provides a valuable extension to any in-house capabilities ensuring that managers, scientists and project leaders meet or exceed their targeted objectives.


CSO: Luc Van Hijfte


Please click here for NovAliX job opportunities.

Key Statistics

Ownership: Private

Web Site: NovAliX


Company News
NovAliX Signs Insourcing Agreement With UCB Biopharma 3/7/2017 7:21:21 AM
NovAliX Turns To High-Resolution Cryo-Transmission Electron Microscopy For Pre-Clinical Drug Discovery Research 3/1/2017 9:50:13 AM
FEI Company And NovAliX Partner To Provide Electron Microscopy-Based Structural Biology Services For The Pharmaceutical Industry 3/21/2016 8:11:52 AM
The NovAliX/Kyowa Hakko Kirin Alliance Will Commence A Fragment-Based Drug Discovery Project Targeting An Important Protein/Protein Interaction 11/18/2013 10:49:47 AM
NovAliX and Inventiva Form a Strategic Alliance on Nuclear Receptors 4/9/2013 12:04:39 PM
NovAliX Enters Into Fragment-Based Drug Discovery Alliance With Kyowa Hakko Kirin 1/14/2013 11:00:24 AM
NovAliX Names Dr. Luc Van Hijfte as CSO Drug Discovery 10/17/2012 10:09:08 AM
NovAliX and Servier Collaborate in Early Discovery Research Program 10/9/2012 1:18:27 PM
NovAliX Enters into Multi-Target Integrated Drug Discovery Collaboration With Teijin Pharma 1/12/2012 9:26:59 AM
NovAliX to Collaborate With the Fondation Jerome Lejeune on Down Syndrome (Trisomy 21) 9/13/2011 11:44:14 AM